According to the Magic Pharmaceutical announcement, the company's stock rose and stopped for three consecutive trading days on August 13, August 14, and August 17, 2026, with a cumulative increase of 33.02%. The cumulative deviation value of the closing price increase exceeded 20%, which is an abnormal fluctuation in stock trading. In the first quarter of 2026, the company achieved revenue of 423 million yuan, a year-on-year decrease of 11.87%, after deducting non-net profit of 126.7772 million yuan, a year-on-year decrease of 15.44%. As of the close of trading on August 17, 2026, the company's dynamic price-earnings ratio was 73.06 times, higher than the industry average. Zhang Zhijun, the controlling shareholder of the company, has reduced its holdings of the company by 1%. The remaining 1.69% of the shares will be reduced through a major transaction. The reduction expires on August 25, 2026. The company currently produces and operates normally, and there is no important information that should be disclosed that has not been disclosed.

According to the Magic Pharmaceutical announcement, the company's stock rose and stopped for three consecutive trading days on August 13, August 14, and August 17, 2026, with a cumulative increase of 33.02%. The cumulative deviation value of the closing price increase exceeded 20%, which is an abnormal fluctuation in stock trading. In the first quarter of 2026, the company achieved revenue of 423 million yuan, a year-on-year decrease of 11.87%, after deducting non-net profit of 126.7772 million yuan, a year-on-year decrease of 15.44%. As of the close of trading on August 17, 2026, the company's dynamic price-earnings ratio was 73.06 times, higher than the industry average. Zhang Zhijun, the controlling shareholder of the company, has reduced its holdings of the company by 1%. The remaining 1.69% of the shares will be reduced through a major transaction. The reduction expires on August 25, 2026. The company currently produces and operates normally, and there is no important information that should be disclosed that has not been disclosed.